Immediate Impact

1 by Nobel laureates 6 from Science/Nature 60 standout
Sub-graph 1 of 22

Citing Papers

Metastasis
2023 Standout
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C
2022 Standout
2 intermediate papers

Works of U. Matulonis being referenced

Phase I/II study of combined BCL-XL and MEK inhibition with navitoclax (N) and trametinib (T) in KRAS or NRAS mutant advanced solid tumours
2019
Phase II and Pharmacokinetic Study of Ecteinascidin 743 in Patients With Progressive Sarcomas of Soft Tissues Refractory to Chemotherapy
2004

Author Peers

Author Last Decade Papers Cites
U. Matulonis 341 118 123 246 126 32 584
Edmonson Jh 246 197 99 157 34 27 560
M.R. Sertoli 433 136 120 72 73 33 625
Katarína Macháleková 255 95 180 167 82 45 660
Linda N. Dao 243 76 193 123 68 28 692
Gerard J. Oakley 267 45 222 242 50 35 724
Rossella De Cecio 377 32 161 237 59 45 672
Melissa Burgess 427 15 96 333 135 51 584
Maria Marples 500 20 174 350 69 30 700
Pia Herbolsheimer 637 100 194 131 106 31 734
Laura Attademo 215 101 163 56 59 21 535

All Works

Loading papers...

Rankless by CCL
2026